8-KLeadership Changes

UNITEDHEALTH GROUP INC 8-K Report, Executive Changes (Jan 4, 2007)

Filed January 4, 2007For Securities:UNH

Summary

This 8-K filing from UnitedHealth Group Incorporated (UNH), dated January 4, 2007, reports on an event that occurred on December 29, 2006. The primary purpose of this filing is to disclose that certain current and former executives have entered into an options repricing agreement with the Company. This action was taken to comply with Section 409A of the Internal Revenue Code, which addresses potential surtax liabilities on deferred compensation, and to take advantage of transitional rules provided by the Treasury Department. While the filing itself does not detail the specifics of the repricing, it signals a proactive measure by the company and its executives to manage tax implications related to stock options. Investors should note that this event relates to historical option grants and their alignment with new tax regulations, rather than an immediate operational or financial performance change. Further details on the terms of the repricing would typically be found in subsequent filings or company disclosures.

Key Highlights

  • 1Disclosure of options repricing agreements for certain current and former executives.
  • 2The repricing is intended to address potential surtax liability under Section 409A of the Internal Revenue Code.
  • 3The action complies with transitional rules permitted by the Treasury Department for Section 409A.
  • 4Key executives involved include Stephen J. Hemsley, David S. Wichmann, Lois E. Quam, and former CEO William W. McGuire, M.D.
  • 5The event date reported is December 29, 2006, with the filing date being January 3, 2007.
  • 6This filing is made under Item 5.02 of Form 8-K, concerning departures or appointments of officers and directors, and compensatory arrangements.

Frequently Asked Questions

The main reason for this filing is to report that UnitedHealth Group's executives have entered into options repricing agreements. This was done to ensure compliance with Section 409A of the Internal Revenue Code, which governs deferred compensation, and to avoid potential tax penalties.

The filing names several current and former executives, including Stephen J. Hemsley, David S. Wichmann, Lois E. Quam, Tracy L. Bahl, Robert J. Sheehy, William W. McGuire, M.D., David J. Lubben, and Patrick J. Erlandson. The inclusion of William W. McGuire, M.D., is notable as he was the CEO at the time.

This filing indicates a repricing of existing options, likely to adjust their terms in light of new tax regulations (Section 409A). It does not necessarily mean new options are being issued, but rather that the terms of certain outstanding options are being modified to comply with tax law, potentially affecting their exercise conditions or price for tax purposes.

Section 409A of the Internal Revenue Code imposes strict rules on non-qualified deferred compensation plans, including stock options. Failure to comply can result in significant additional taxes and penalties for the executive holding the options. This filing suggests the company is taking steps to ensure its executive stock option arrangements meet these requirements.